MORE►
biotech
[Image: Natali_Mis/istockphoto]
Bedford Biotech Restores “Meaningful Vision” in Blind Patients With Gene Therapy—and May Soon Go Public
by David Seeley | Jun 22, 2021
Nanoscope Therapeutics successfully treated 11 patients blinded by advanced retinitis pigmentosa (RP). A single intravitreal injection produced positive results that persisted through one year. The startup plans a Phase 2b trial this summer and plans to develop gene therapies to treat more common retinal diseases—like dry age-related macular degeneration.
by Alex Edwards |
Jun 17, 2021
The investment was led by Advantech Capital, a PE fund based in China that focuses on TMT, pharmaceuticals, and healthcare. This combined with the support from the Cancer Prevention and Research Institute of Texas (CPRIT), which granted OncoNano $9.97 million last year, will support Phase 3 clinical trials for the biotech's technology that can diagnose and treat cancer with high specificity.
MORE►
by Alex Edwards |
Mar 8, 2021
As CMO at the Dallas-based biotech, Jessica Hilton is part of a team working to launch the first-ever long-lasting cleaner that can fight COVID-19. It's a job she took during the middle of the global pandemic—and though her home life looks a little different, the mom of three is managing it all through a deep-seeded passion and supportive family.
MORE►
by Quincy Preston |
Feb 26, 2021
In under six months, Taysha Gene Therapies rocketed from the unveiling of its UTSW spinout to a $157 million initial public offering. We talk with Founder and CEO R.A. Session II about the biotech with big plans.
MORE►
Riding the Funding Wave: These DFW Startups Got the Money in 2020
by Quincy Preston and Sandra Engelland | Feb 11, 2021
Here are 32 North Texas startups that successfully pulled in capital to back their ventures.
Fitting the digital demands of a global pandemic, it's a tech-heavy group, with liberal doses of biotech and healthcare-related firms.
MORE►
by Alex Edwards |
Feb 10, 2021
The agreement will involve the two companies providing educational programs and connections for scientist entrepreneurs located at the Biotech+ Hub at Pegasus Park.
MORE►
by Lauren Hawkins |
Dec 8, 2020
Dallas life science startups are invited to apply to ThinkLab's winter cohort, which will begin in late January 2021.
MORE►
by Alex Edwards |
Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE►
Health Wildcatters co-founder and CEO Hubert Zajicek [Image: Courtesy Health Wildcatters]
Health Wildcatters Co-Founder and CEO Hubert Zajicek To Receive 2020 Dennis K. Stone Award
by Lauren Hawkins | Oct 27, 2020
The Dallas-based leader will receive the award from BionorthTX for his contributions to the field of life sciences.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Quincy Preston |
Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists.
UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE►
![Illustration of the Orthofix FIREBIRD SI Fusion System with NANOVATE technology [PHOTO: Business Wire]](https://s24806.pcdn.co/wp-content/uploads/2020/10/Orthofix-970-businesswire-360x203.jpg)
by Quincy Preston |
Oct 7, 2020
The Lewisville-based company's new fusion system is designed to compress and stabilize the sacroiliac joint. Its high-tech features make it the first of its kind specifically designed for SI joint solutions.
Other recent news includes a $10 million partnership with a Swiss medtech firm and a new division president.
Other recent news includes a $10 million partnership with a Swiss medtech firm and a new division president.
MORE►
![At the Fourth Annual iC3 Life Science Summit at UT Arlington on Oct. 10, 2017 recipient Lyda Hill will present the award. To register for the summit, visit www.bionorthtx.org. [Illustration: bestbrk/istockphoto]](https://s24806.pcdn.co/wp-content/uploads/2018/09/Bionorthconcept_970_bestbrk_istockphotovector-molecule-background-genetic-and-chemical-compounds-abstract-vector-id908258902-940x436.jpg)
[Illustration: bestbrk/istockphoto]
Bio North Texas Shifts iC3 Life Sciences Summit to Virtual Event
by Quincy Preston | Sep 22, 2020
Networking—always a highlight of the biotech event— is still a cornerstone thanks to a new virtual conference platform, its organizers said.
MORE►
by Alex Edwards |
Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
MORE►
by Quincy Preston |
Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
MORE►
by Alex Edwards |
Aug 24, 2020
The U.S. Environmental Protection Agency has given approval to Allied BioScience for its electrostatic spraying solution, SurfaceWise2. The next-gen coating will give critical protection to Texas-based companies like early partner American Airlines.
MORE►
